RPAM
ALPN

Rhenman & Partners Asset Management’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History

Rhenman & Partners Asset Management’s Portfolio ALPN Stock Details ALPN Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-85,500
Closed -$3.39M – 98
2024
Q1 		$3.39M Buy
+85,500
New +$3.39M 0.32% 62